Cardiac CAMP-PKA Signaling Compartmentalization in Myocardial Infarction
Overview
Biophysics
Cell Biology
Molecular Biology
Authors
Affiliations
Under physiological conditions, cAMP signaling plays a key role in the regulation of cardiac function. Activation of this intracellular signaling pathway mirrors cardiomyocyte adaptation to various extracellular stimuli. Extracellular ligand binding to seven-transmembrane receptors (also known as GPCRs) with G proteins and adenylyl cyclases (ACs) modulate the intracellular cAMP content. Subsequently, this second messenger triggers activation of specific intracellular downstream effectors that ensure a proper cellular response. Therefore, it is essential for the cell to keep the cAMP signaling highly regulated in space and time. The temporal regulation depends on the activity of ACs and phosphodiesterases. By scaffolding key components of the cAMP signaling machinery, A-kinase anchoring proteins (AKAPs) coordinate both the spatial and temporal regulation. Myocardial infarction is one of the major causes of death in industrialized countries and is characterized by a prolonged cardiac ischemia. This leads to irreversible cardiomyocyte death and impairs cardiac function. Regardless of its causes, a chronic activation of cardiac cAMP signaling is established to compensate this loss. While this adaptation is primarily beneficial for contractile function, it turns out, in the long run, to be deleterious. This review compiles current knowledge about cardiac cAMP compartmentalization under physiological conditions and post-myocardial infarction when it appears to be profoundly impaired.
Santoro R, Piacentini L, Vavassori C, Benzoni P, Colombo G, Banfi C Mater Today Bio. 2025; 31:101566.
PMID: 40061214 PMC: 11889630. DOI: 10.1016/j.mtbio.2025.101566.
Man K, Fu L, Lane A, Harris F, Reid O, Armand L Life Sci. 2025; 364:123434.
PMID: 39892862 PMC: 11834986. DOI: 10.1016/j.lfs.2025.123434.
Samadishadlou M, Rahbarghazi R, Kavousi K, Bani F Biol Direct. 2024; 19(1):127.
PMID: 39658789 PMC: 11629498. DOI: 10.1186/s13062-024-00543-5.
Salbutamol attenuates arrhythmogenic effect of aminophylline in a hPSC-derived cardiac model.
Kabanov D, Vrana Klimovic S, Beckerova D, Molcan M, Scurek M, Brat K Sci Rep. 2024; 14(1):27399.
PMID: 39521810 PMC: 11550379. DOI: 10.1038/s41598-024-76846-4.
PDE4 inhibitors: potential protective effects in inflammation and vascular diseases.
Fan T, Wang W, Wang Y, Zeng M, Liu Y, Zhu S Front Pharmacol. 2024; 15:1407871.
PMID: 38915460 PMC: 11194378. DOI: 10.3389/fphar.2024.1407871.